Stempeutics Research Private
Manufacturing · India · 11-50 Employees
View Company Info for Free
Overview
Headquarters
#143 Hospitals Fl 3, Manipal, Karnataka,...Phone Number
+91 8025028101Website
www.stempeutics.comRevenue
$16.2 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Stempeutics Research Private
Stempeutics is a life science company based in Bangalore, focused on developing and commercializing innovative therapeutics utilizing adult stem cells. Their flagship product, Stempeucel, is the first patented cell therapy approved for treating Knee Osteoarthritis and Critical Limb Ischemia in India. In addition to therapeutics, Stempeutics offers a range of bio-cosmetic products for skin, hair, and under-eye care. The company aims to deliver safe, effective, and affordable stem cell-based solutions to healthcare providers and patients.Explore more
Stempeutics Research Private Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Stempeutics Research Private your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Stempeutics Research Private is spiking on competitors!
Stempeutics Research Private, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Stempeutics Research Private launches new products
Funding: Get notified immidiatlly once Stempeutics Research Private has new funding data
Click to see if Stempeutics Research Private had a recent Job posting/layoffs
Check if Stempeutics Research Private has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Stempeutics Research Private recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Stempeutics Research Private
Recommended Actions
Reach out to Masked Content who joined Stempeutics Research Private as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Stempeutics Research Private is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Stempeutics Research Private is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Stempeutics Research Private.
Stempeutics Research Private Tech Stack
A closer look at the technologies used by Stempeutics Research Private
Stempeutics Research Private News & Media
Stempeutics gets DCGI nod for Phase 3 trial to treat Covid patients
Stempeutics said it has received DCGI clearance to conduct Phase 3 clinical trial on its product for treating COVID-19 patients suffering from acute respiratory distress syndrome (ARDS).Cipla and Stempeutics collaborate for launch of Stempeucel®, first 'Made in India' Cell Therapy to treat Critical Limb Ischemia (CLI)
- First approved allogeneic cell therapy product globally for the treatment of CLI - Developed by Stempeutics over a period of twelve years, breakthrough treatment designed to address root cause of the disease at an affordable cost - Cipla to market and distribute the drug in India to provide patient access MUMBAI, India, Aug. 21, 2020 /PRNewswire/ -- Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) referred to as "Cipla" today announced that its partner Stempeutics Research
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Stempeutics Research Private
Sign Up For FreeTo access detailed company insights
Stempeutics is a life science company based in Bangalore, focused on developing and commercializing innovative therapeutics utilizing adult stem cells. Their flagship product, Stempeucel, is the first patented cell therapy approved for treating Knee Osteoarthritis and Critical Limb Ischemia in India. In addition to therapeutics, Stempeutics offers... Read More
